Alice M McSweeney, Alice-Roza Eruera, Geena M McKenzie-Goldsmith, James C Bouwer, Simon H J Brown, Louise A Stubbing, Jonathan G Hubert, Rinu Shrestha, Kevin J Sparrow, Margaret A Brimble, Lawrence D Harris, Gary B Evans, Mihnea Bostina, Kurt L Krause, Vernon K Ward
{"title":"人类诺如病毒 ProPol 前体聚合酶结构域的活性和低温电子显微镜结构。","authors":"Alice M McSweeney, Alice-Roza Eruera, Geena M McKenzie-Goldsmith, James C Bouwer, Simon H J Brown, Louise A Stubbing, Jonathan G Hubert, Rinu Shrestha, Kevin J Sparrow, Margaret A Brimble, Lawrence D Harris, Gary B Evans, Mihnea Bostina, Kurt L Krause, Vernon K Ward","doi":"10.1128/jvi.01193-24","DOIUrl":null,"url":null,"abstract":"<p><p>Human norovirus (HuNV) is a leading cause of acute gastroenteritis worldwide with most infections caused by genogroup I and genogroup II (GII) viruses. Replication of HuNV generates both precursor and mature proteins during processing of the viral polyprotein that are essential to the viral lifecycle. One such precursor is protease-polymerase (ProPol), a multi-functional enzyme comprised of the norovirus protease and polymerase proteins. This work investigated HuNV ProPol by determining the <i>de novo</i> polymerase activity, protein structure, and antiviral inhibition profile. The GII ProPol <i>de novo</i> enzymatic efficiencies (<i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>) for RNA templates and ribonucleotides were equal or superior to those of mature GII Pol on all templates measured. Furthermore, GII ProPol was the only enzyme form active on a poly(A) template. The first structure of the polymerase domain of HuNV ProPol in the unliganded state was determined by cryo-electron microscopy at a resolution of 2.6 Å. The active site and overall architecture of ProPol are similar to those of mature Pol. In addition, both galidesivir triphosphate and PPNDS inhibited polymerase activity of GII ProPol, with respective half-maximal inhibitory concentration (IC<sub>50</sub>) values of 247.5 µM and 3.8 µM. In both instances, the IC<sub>50</sub> obtained with ProPol was greater than that of mature Pol, indicating that ProPol can exhibit different responses to antivirals. This study provides evidence that HuNV ProPol possesses overlapping and unique enzyme properties compared with mature Pol and will aid our understanding of the replication cycle of the virus.IMPORTANCEDespite human norovirus (HuNV) being a leading cause of acute gastroenteritis, the molecular mechanisms surrounding replication are not well understood. Reports have shown that HuNV replication generates precursor proteins from the viral polyprotein, one of which is the protease-polymerase (ProPol). This precursor is important for viral replication; however, the polymerase activity and structural differences between the precursor and mature forms of the polymerase remain to be determined. We show that substrate specificity and polymerase activity of ProPol overlap with, but is distinct from, the mature polymerase. We employ cryo-electron microscopy to resolve the first structure of the polymerase domain of ProPol. This shows a polymerase architecture similar to mature Pol, indicating that the interaction of the precursor with substrates likely defines its activity. We also show that ProPol responds differently to antivirals than mature polymerase. Altogether, these findings enhance our understanding of the function of the important norovirus ProPol precursor.</p>","PeriodicalId":17583,"journal":{"name":"Journal of Virology","volume":" ","pages":"e0119324"},"PeriodicalIF":4.0000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575396/pdf/","citationCount":"0","resultStr":"{\"title\":\"Activity and cryo-EM structure of the polymerase domain of the human norovirus ProPol precursor.\",\"authors\":\"Alice M McSweeney, Alice-Roza Eruera, Geena M McKenzie-Goldsmith, James C Bouwer, Simon H J Brown, Louise A Stubbing, Jonathan G Hubert, Rinu Shrestha, Kevin J Sparrow, Margaret A Brimble, Lawrence D Harris, Gary B Evans, Mihnea Bostina, Kurt L Krause, Vernon K Ward\",\"doi\":\"10.1128/jvi.01193-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Human norovirus (HuNV) is a leading cause of acute gastroenteritis worldwide with most infections caused by genogroup I and genogroup II (GII) viruses. Replication of HuNV generates both precursor and mature proteins during processing of the viral polyprotein that are essential to the viral lifecycle. One such precursor is protease-polymerase (ProPol), a multi-functional enzyme comprised of the norovirus protease and polymerase proteins. This work investigated HuNV ProPol by determining the <i>de novo</i> polymerase activity, protein structure, and antiviral inhibition profile. The GII ProPol <i>de novo</i> enzymatic efficiencies (<i>k</i><sub>cat</sub>/<i>K</i><sub>m</sub>) for RNA templates and ribonucleotides were equal or superior to those of mature GII Pol on all templates measured. Furthermore, GII ProPol was the only enzyme form active on a poly(A) template. The first structure of the polymerase domain of HuNV ProPol in the unliganded state was determined by cryo-electron microscopy at a resolution of 2.6 Å. The active site and overall architecture of ProPol are similar to those of mature Pol. In addition, both galidesivir triphosphate and PPNDS inhibited polymerase activity of GII ProPol, with respective half-maximal inhibitory concentration (IC<sub>50</sub>) values of 247.5 µM and 3.8 µM. In both instances, the IC<sub>50</sub> obtained with ProPol was greater than that of mature Pol, indicating that ProPol can exhibit different responses to antivirals. This study provides evidence that HuNV ProPol possesses overlapping and unique enzyme properties compared with mature Pol and will aid our understanding of the replication cycle of the virus.IMPORTANCEDespite human norovirus (HuNV) being a leading cause of acute gastroenteritis, the molecular mechanisms surrounding replication are not well understood. Reports have shown that HuNV replication generates precursor proteins from the viral polyprotein, one of which is the protease-polymerase (ProPol). This precursor is important for viral replication; however, the polymerase activity and structural differences between the precursor and mature forms of the polymerase remain to be determined. We show that substrate specificity and polymerase activity of ProPol overlap with, but is distinct from, the mature polymerase. We employ cryo-electron microscopy to resolve the first structure of the polymerase domain of ProPol. This shows a polymerase architecture similar to mature Pol, indicating that the interaction of the precursor with substrates likely defines its activity. We also show that ProPol responds differently to antivirals than mature polymerase. Altogether, these findings enhance our understanding of the function of the important norovirus ProPol precursor.</p>\",\"PeriodicalId\":17583,\"journal\":{\"name\":\"Journal of Virology\",\"volume\":\" \",\"pages\":\"e0119324\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575396/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Virology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1128/jvi.01193-24\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/jvi.01193-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
人类诺如病毒(HuNV)是全球急性肠胃炎的主要病因,大多数感染由基因组 I 和基因组 II (GII) 病毒引起。HuNV 复制过程中会产生对病毒生命周期至关重要的前体蛋白和成熟蛋白。其中一种前体蛋白是蛋白酶聚合酶(ProPol),这是一种由诺如病毒蛋白酶和聚合酶蛋白组成的多功能酶。这项研究通过确定从头聚合酶活性、蛋白质结构和抗病毒抑制谱,对 HuNV ProPol 进行了研究。在所有测得的模板上,GII ProPol 对 RNA 模板和核糖核苷酸的从头酶效率(kcat/Km)与成熟的 GII Pol 相等或更高。此外,GII ProPol 是唯一一种在聚(A)模板上具有活性的酶形式。通过低温电子显微镜测定了 HuNV ProPol 的聚合酶结构域在无连接状态下的第一个结构,分辨率为 2.6 Å。此外,三磷酸加来替韦和 PPNDS 都能抑制 GII ProPol 的聚合酶活性,其半最大抑制浓度(IC50)值分别为 247.5 µM 和 3.8 µM。在这两种情况下,ProPol 的 IC50 值都大于成熟 Pol 的 IC50 值,这表明 ProPol 对抗病毒药物会表现出不同的反应。这项研究提供了证据,证明与成熟 Pol 相比,HuNV ProPol 具有重叠和独特的酶特性,这将有助于我们了解病毒的复制周期。 重要意义尽管人诺如病毒(HuNV)是急性肠胃炎的主要病因,但人们对其复制的分子机制还不是很了解。有报告显示,HuNV 复制会从病毒多聚蛋白中产生前体蛋白,蛋白酶聚合酶(ProPol)就是其中之一。这种前体蛋白对病毒复制非常重要;然而,前体蛋白和成熟形式的聚合酶之间的聚合酶活性和结构差异仍有待确定。我们的研究表明,ProPol 的底物特异性和聚合酶活性与成熟聚合酶重叠,但又有所不同。我们利用低温电子显微镜首次解析了 ProPol 聚合酶结构域的结构。它显示出与成熟 Pol 相似的聚合酶结构,表明前体与底物的相互作用可能决定了它的活性。我们还发现 ProPol 对抗病毒药物的反应与成熟聚合酶不同。总之,这些发现加深了我们对重要的诺如病毒 ProPol 前体功能的了解。
Activity and cryo-EM structure of the polymerase domain of the human norovirus ProPol precursor.
Human norovirus (HuNV) is a leading cause of acute gastroenteritis worldwide with most infections caused by genogroup I and genogroup II (GII) viruses. Replication of HuNV generates both precursor and mature proteins during processing of the viral polyprotein that are essential to the viral lifecycle. One such precursor is protease-polymerase (ProPol), a multi-functional enzyme comprised of the norovirus protease and polymerase proteins. This work investigated HuNV ProPol by determining the de novo polymerase activity, protein structure, and antiviral inhibition profile. The GII ProPol de novo enzymatic efficiencies (kcat/Km) for RNA templates and ribonucleotides were equal or superior to those of mature GII Pol on all templates measured. Furthermore, GII ProPol was the only enzyme form active on a poly(A) template. The first structure of the polymerase domain of HuNV ProPol in the unliganded state was determined by cryo-electron microscopy at a resolution of 2.6 Å. The active site and overall architecture of ProPol are similar to those of mature Pol. In addition, both galidesivir triphosphate and PPNDS inhibited polymerase activity of GII ProPol, with respective half-maximal inhibitory concentration (IC50) values of 247.5 µM and 3.8 µM. In both instances, the IC50 obtained with ProPol was greater than that of mature Pol, indicating that ProPol can exhibit different responses to antivirals. This study provides evidence that HuNV ProPol possesses overlapping and unique enzyme properties compared with mature Pol and will aid our understanding of the replication cycle of the virus.IMPORTANCEDespite human norovirus (HuNV) being a leading cause of acute gastroenteritis, the molecular mechanisms surrounding replication are not well understood. Reports have shown that HuNV replication generates precursor proteins from the viral polyprotein, one of which is the protease-polymerase (ProPol). This precursor is important for viral replication; however, the polymerase activity and structural differences between the precursor and mature forms of the polymerase remain to be determined. We show that substrate specificity and polymerase activity of ProPol overlap with, but is distinct from, the mature polymerase. We employ cryo-electron microscopy to resolve the first structure of the polymerase domain of ProPol. This shows a polymerase architecture similar to mature Pol, indicating that the interaction of the precursor with substrates likely defines its activity. We also show that ProPol responds differently to antivirals than mature polymerase. Altogether, these findings enhance our understanding of the function of the important norovirus ProPol precursor.
期刊介绍:
Journal of Virology (JVI) explores the nature of the viruses of animals, archaea, bacteria, fungi, plants, and protozoa. We welcome papers on virion structure and assembly, viral genome replication and regulation of gene expression, genetic diversity and evolution, virus-cell interactions, cellular responses to infection, transformation and oncogenesis, gene delivery, viral pathogenesis and immunity, and vaccines and antiviral agents.